Abstract
The subject of organ retransplantation has generated a great deal of debate and discussion as physicians, ethicists and health care payers as well as patients address such intrinsically conflicting principles as distributive justice and the drive to maximize individual patient survival. As is the case with other organ allografts, it is inevitable that a certain number of cardiac allograft recipients will redevelop some form of end-stage heart disease and become potential candidates for retransplantation. While there may be no strictly right or wrong answer to the question of whether heart retransplantation should ever be performed, we felt that examining the experience at a single relatively high-volume institution which has performed retransplantation over a several decade period could be instructive both in terms of assessing what the best result to be obtained might be as well as identifying subsets of retransplant candidates with predictable better outcome than others. Thus, we present a retrospective analysis of our institutions 2.9 year experience with cardiac retransplantation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J. Chronic Dis. 1958; 8: 699–712.
Gehan A. Generalized Wilcoxon test for comparing arbitrary single-censored samples. Biometrika 1965; 52: 203–222.
Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB et al. Task force 3: recipient guidelines/prioritization. J. Amer. Coll. Cardiol. 1993; 22: 21–31.
Hosenpid JD, Novick RJ, Bennet LE, Keck BM, Fiol B, Daily OP. The Registry of the International Society for Heart Lung Transplantation: thirteenth official report-1996. J. Heart Lung Transplant. 1996; 15: 655–674.
O’Connell JB, Gunnar RM, Evans RW, Fricker J, Hunt SA, Kirklin JK. Task Force 1: organization of heart transplantation in the U.S. In: 24th Bethesda Conference. J. Am. Coll. Cardiol. 1993; 22: 8–14.
Skolnick AA. Transplantion pioneer predicts successful xenotransplant soon. JAMA 1993; 269: 2951–2958.
Oz MC, Argenziano M, Catanese KA, Gardocki MT, Goldstein DJ, Ashton RC et al. Bridge experience with long-term implantable left ventricular assist devices: are they an alternative to transplantation? Circulation 1997; 95: 1844–1852.
Mills RM, Naftel DC, Kirklin JK, Van Bakel A, Jaski B, Massin E. Cardiac transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial cellular infiltrate. J. Heart Lung Transplant. (in press).
Keogh AM, Valantine HA, Hunt SA, Schroeder JS, McIntosh N, Oyer PE, Stinson EB. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J. Heart Transplant. 1992; 11: 892–901.
Ensley RD, Hunt S, Taylor DO, Renlund DG, Menlove RL, Karwande SV et al. J. Heart Lung Transplant. 1992; 11: S 142–158.
Ubel PA, Arnold RM, Caplan AL. Rationing failure: the ethical lessons of the retransplantation of scarce vital organs. JAMA 1993; 270: 2469–2474.
Rights and permissions
Copyright information
© 1997 Kluwer Academic Publishers
About this chapter
Cite this chapter
Hunt, S.A., Robbins, R.C., Stinson, E.B., Dyer, P.E., Shumway, N.E., Reitz, B.A. (1997). A single center experience with heart retransplantation: the 29 year experience at a single institution. In: Retransplantation. Transplantation and Clinical Immunology, vol 29. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-38142-8_28
Download citation
DOI: https://doi.org/10.1007/978-0-585-38142-8_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-4937-2
Online ISBN: 978-0-585-38142-8
eBook Packages: Springer Book Archive